Harrow
John Solter is currently employed as an Organizational Operations Development Manager at Harrow, where John has been working since October 2023. Prior to this role, John served as a Special Operations Officer at the U.S. Marine Corps Forces Special Operations Command (MARSOC) from January 2019 to October 2023, and as an Infantry Officer at the 1st Marine Division from October 2015 to January 2019.
John has also interned at the U.S. House of Representatives, worked as an Ocean Lifeguard at Brevard County Fire & Rescue, and completed various educational programs, including earning a Master's in Business Administration from Grand Canyon University.
This person is not in any teams
This person is not in any offices
Harrow
2 followers
Harrow (Nasdaq: HROW) is a leading U.S. eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic prescription therapies that are accessible and affordable. Harrow owns U.S. commercial rights to ten FDA-approved ophthalmic pharmaceutical products. Harrow also owns and operates ImprimisRx, the leading U.S. ophthalmic‑focused pharmaceutical compounding business, which also serves as a mail-order pharmacy licensed to ship prescription medications in all 50 states. Harrow has non-controlling equity positions in Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc., companies that began as subsidiaries of Harrow. Harrow also owns royalty rights in four late-stage drug candidates being developed by Surface and Melt.